Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Resmed Inc shares valued at $241,438 were sold by FARRELL PETER C on Jul 02 ’25. At $255.49 per share, FARRELL PETER C sold 945 shares. The insider’s holdings dropped to 68,273 shares worth approximately $17.54 million following the completion of this transaction.
Also, Sandercock Brett sold 3,883 shares, netting a total of over 997,892 in proceeds. Following the sale of shares at $256.99 each, the insider now holds 84,283 shares.
Before that, FARRELL PETER C had added 945 shares to its account. In a trade valued at $250,000, the Director bought Resmed Inc shares for $264.55 each.
As published in their initiating research note from Morgan Stanley on March 19, 2025, Resmed Inc [RMD] has been an Overweight and the price target has been revised to $280. Analysts at Morgan Stanley started covering the stock with ‘”an Overweight”‘ outlook in a report released in mid March. As of January 16, 2025, Goldman has initiated its “Buy” rating for RMD. Earlier on January 10, 2025, Piper Sandler initiated its rating. Their recommendation was “a Neutral” for RMD stock.
Analyzing RMD Stock Performance
On last trading session, Resmed Inc [NYSE: RMD] rose 0.42% to $256.96. The stock’s lowest price that day was $253.94, but it reached a high of $257.625 in the same session. During the last five days, there has been a surge of approximately 0.29%. Over the course of the year, Resmed Inc shares have jumped approximately 37.46%. Shares of the company reached a 52-week high of $263.05 on 01/30/25 and a 52-week low of $199.92 on 04/07/25.
Support And Resistance Levels for Resmed Inc (RMD)
According to the 24-hour chart, there is a support level at 254.72, which, if violated, would cause prices to drop to 252.49. In the upper region, resistance lies at 258.41. The next price resistance is at 259.86. RSI (Relative Strength Index) is 61.87 on the 14-day chart, showing neutral technical sentiment.
Is Resmed Inc subject to short interest?
Stocks of Resmed Inc saw a sharp steep in short interest on 2025-06-13 dropping by -1.01 million shares to 9.93 million. Data from Yahoo Finance shows that the short interest on 2025-05-15 was 10.93 million shares. A decline of -10.12% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 11.58 of the overall float, the days-to-cover ratio (short ratio) decline to 11.58.
Which companies own the most shares of Resmed Inc (RMD)?
In terms of Resmed Inc share price expectations, FactSet research, analysts set an average price target of 265 in the next 12 months, up nearly 3.56% from the previous closing price of $255.88. Analysts anticipate Resmed Inc stock to reach 286 by 2025, with the lowest price target being 240. In spite of this, 19 analysts ranked Resmed Inc stock as Buy at the end of 2025. On December 13, 2024, Stifel assigned a price target of “a Hold” to the stock and initiated coverage with a $250.
